Actelion shareholders back incumbents at AGM
This article was originally published in Scrip
Executive Summary
Actelion shareholders rejected an attempt by activist hedge fund Elliott Advisors to oust the incumbent management at the Swiss biotech's annual general meeting on 5 May.